Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
---|
01/08/2009 | CA2660778A1 Near infrared-fluorescence using phospholipid ether analog dyes in endoscopic applications |
01/07/2009 | EP2011520A1 Kit for Radiolabeling Proteins with Yttrium-90 |
01/07/2009 | EP2010227A2 Radiofluorinated compounds and their preparation |
01/07/2009 | EP2010212A2 Anti ku70 internalizing antibodies |
01/07/2009 | EP1581790B1 Peptides that home to tumor lymphatic vasculature and methods of using same |
01/07/2009 | EP1401507B1 Stabilization of radionuclide-containing compositions |
01/07/2009 | CN101338303A Adenovirus marked by radionuclide |
01/07/2009 | CN101337081A Medicine box for preparing 99mTc complex and preparation method and use thereof |
01/07/2009 | CN101337080A Radionuclide particle implantation medicine for cancer, use and preparation method thereof |
01/06/2009 | US7473761 Therapy for metabolic disorders; polycystic kidney diseasel diarrhea; gastrointestinal disorders |
01/06/2009 | US7473682 Angiogenic peptides and uses thereof |
01/06/2009 | US7473415 Near infrared fluorescent contrast agent and method for fluorescence imaging |
01/06/2009 | CA2345545C Radioactively coated devices |
01/06/2009 | CA2149770C Detection of hypoxia |
01/06/2009 | CA2144406C Gene transcription and ionizing radiation: methods and compositions |
01/01/2009 | US20090005617 Synthesis of a radioactive 18-fluorine isotope-labeled imaging compound using a positron emission tomograph or magnetic resonance; more flexible results by placing the anion exchange device partially in the measurement chamber to measure [18F]fluoride ions in the anion exchange device; efficiency |
01/01/2009 | US20090005595 Gentisic Acid for Stabilising 123-I Radiopharmaceuticals |
01/01/2009 | US20090005545 Methods for purifying radiolabelled compounds |
01/01/2009 | US20090005328 Methods of modulating tubulin deacetylast activity |
01/01/2009 | US20090004109 Antibodies and Molecules Derived Therefrom that Bind to Steap-1 Proteins |
01/01/2009 | US20090004107 Beta-amyloid and neurofibrillary tangle imaging agents |
01/01/2009 | US20090004106 Radioligands for the 5 -Ht1b Receptor |
01/01/2009 | US20090004105 Molecular imaging of matrix metalloproteinase expression using labeled chlorotoxin |
01/01/2009 | US20090004104 Methods and Compositions for Delivering Active Agents with Enhanced Pharmacological Properties |
01/01/2009 | US20090004103 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
01/01/2009 | US20090004102 HSC70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
01/01/2009 | US20090004101 Method and Means for Enhanced Pulmonary Drug Delivery |
12/31/2008 | WO2009002669A2 Small peptides specifically bind to colorectal cancers |
12/31/2008 | WO2009001046A2 [11c]methoxy-radiolabelled 2,3',4,5'-tetramethylstilbene (tms) and its preparation and use |
12/31/2008 | WO2009000785A2 Compositions emitting positrons and containing inorganic particles, and use thereof in medicine, especially for diagnostic processes |
12/31/2008 | WO2009000777A2 Imaging diagnostics by combining contrast agents |
12/31/2008 | WO2008026051A9 68ga-labelling of a free and macromolecule conjugated macrocyclic chelator at ambient temperature |
12/31/2008 | WO2008005889A3 Tetanus toxin fragment c based imaging agents and methods, and confocal microscopy dataset processes |
12/31/2008 | EP2009443A1 Diagnostic agent and therapeutic agent for pancreatic cancer |
12/31/2008 | EP2007435A2 System for targeted delivery of therapeutic agents |
12/31/2008 | EP2007340A1 Integrated pharmaceutical production, quality assurance, and safety system (iqs) |
12/31/2008 | EP1350085B1 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc) |
12/31/2008 | CN101336114A Radiolabelling method using polymers |
12/31/2008 | CN101333259A Preparation of <99m>Tc galactosyl human serum albumin fusion interferon of liver receptor developer and uses thereof |
12/31/2008 | CN101333138A Device and process capable of simultaneously preparing three different <18>F radiopharmaceuticals |
12/31/2008 | CN100447159C Antibodies to ED-8 domain of fibronectin, their construction and uses |
12/31/2008 | CA2691580A1 Compositions emitting positrons and containing inorganic particles, and use thereof in medicine, especially for diagnostic processes |
12/30/2008 | US7470775 Anti-CD30 stalk and anti-CD30 antibodies suitable for use in immunotoxins |
12/30/2008 | US7470698 Adenosine A3 receptor modulators |
12/30/2008 | CA2391293C .beta.2-adrenergic receptor agonists |
12/30/2008 | CA2250295C Water soluble paclitaxel prodrugs |
12/25/2008 | US20080317668 Integrin Targeted Synthetic Ligands for Diagnostic and Therapeutic Applications |
12/25/2008 | US20080317667 Compositions and methods for inhibiting growth of smad4-deficient cancers |
12/25/2008 | US20080317666 Colonic Delivery of Active Agents |
12/24/2008 | WO2008157161A1 Anti-il-20 antibody and its use in treating il-20 associated inflammatory diseases |
12/24/2008 | WO2008156503A1 Compositions for delivery of therapeutics and other materials |
12/24/2008 | WO2008134618A3 Novel imaging tracers for early detection and treatment of amyloid plaques caused by alzheimer's disease and related disorders |
12/24/2008 | WO2007103162A3 Structure based drug design of steroidogenesis inhibitors |
12/24/2008 | EP2005973A1 Compositions containing positron emitting inorganic particles and their use in medicine, in particular for diagnostic procedures |
12/24/2008 | EP2005970A1 Imaging diagnosis by combining contrast agents |
12/24/2008 | EP2004642A1 Bifunctional polyazamacrocyclic chelating agents |
12/24/2008 | EP1521741B1 Imaging compounds |
12/24/2008 | CN201168080Y Repeatedly-usable stent for human body lumens |
12/24/2008 | CA2691892A1 Anti-il-20 antibody and its use in treating il-20 associated inflammatory diseases |
12/23/2008 | US7468394 Mixing propofol, oil and egg lecithin, adding mixture of water and glycerin; entrapping propofol within shells of liposome particles; emulsification by use of a homogenizer, adjusting final volume and pH,filling, closing and sealing, sterilization, candling, packaging |
12/23/2008 | US7468350 Glue composition for lung volume reduction |
12/23/2008 | US7468254 Cytotoxicity mediation of cells evidencing surface expression of MCSP |
12/23/2008 | CA2371176C Assays for nucleoside diphosphates and triphosphates |
12/23/2008 | CA2249320C Glycosylated humanized b-cell specific antibodies |
12/18/2008 | US20080312446 Imaging agents for diagnosis of parkinson's disease |
12/18/2008 | US20080312407 Glycopeptide phosphonate derivatives |
12/18/2008 | US20080311107 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
12/18/2008 | US20080311038 Radicicol Derivatives Useful for Position Emission Tomography |
12/18/2008 | US20080311037 Compounds which bind PSMA and uses thereof |
12/18/2008 | US20080311036 Imaging of Neural and Organ Injury or Damage |
12/18/2008 | US20080311035 Diagnostic Agents For Positron Emission Imaging Using Radiolabeled Halogenated Xanthenes |
12/18/2008 | US20080311034 Anti-Tissue Factor Antibodies and Compositions with Enhanced Effector Function |
12/17/2008 | EP1814599A4 Combination therapy using transferrin fusion proteins comprising glp-1 |
12/17/2008 | EP1572695B1 Porphyrin derivatives, methods for obtaining same, and use thereof in radioimmunotherapy |
12/17/2008 | EP1463065B1 Processes for producing 15o-carbon monoxide and 15o-carbon dioxide and production apparatus |
12/17/2008 | EP1333865B1 Inorganic low density radionuclide coated particles |
12/17/2008 | EP1007696B1 Il-13 receptor specific chimeric proteins and uses thereof |
12/17/2008 | CN101325978A Novel imaging agents for fibrosis |
12/17/2008 | CN101322849A Radioactive sustained-release particle and preparation and use thereof |
12/17/2008 | CN100443476C Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
12/16/2008 | US7465449 Anti-αvβ6 antibodies |
12/16/2008 | CA2249173C Diagnostic agent for liver function |
12/11/2008 | WO2008151226A1 Treatment of vertebral cancer with 153 samarium |
12/11/2008 | WO2008151003A2 Novel fluorine-18 labeled rhodamine derivatives for myocardial perfusion imaging with positron emission tomography |
12/11/2008 | WO2008148877A2 Paramagnetic biomolecule complexes and uses thereof in the assessment of organ function |
12/11/2008 | WO2008134289A3 High relaxivity coordinatively unsaturated lanthanide complexes |
12/11/2008 | US20080306085 Non-imidazole aryloxyalkylamines |
12/11/2008 | US20080305042 Radiolabelling Method Using Polymers |
12/11/2008 | US20080305041 Pf4 Pharmacophores and Their Uses |
12/11/2008 | US20080305040 In Vivo or in Vitro Method For Detecting Amyloid Deposits Having at Least One Amyloidogenic Protein |
12/11/2008 | US20080305039 Facilitated Transport of Bisphosphonates by Vitamin C |
12/11/2008 | US20080305038 Transport of Nano-and Macromolecular Structures Into Cytoplasm and Nucleus of Cells |
12/11/2008 | US20080305037 Linkers for anchoring targeting ligands |
12/11/2008 | CA2721401A1 Paramagnetic biomolecule complexes and uses thereof in the assessment of organ function |
12/10/2008 | EP2000545A1 Compositions and methods for the diagnosis and treatment of tumor |
12/10/2008 | EP2000482A1 Compositions and methods for the diagnosis and treatment of tumor |
12/10/2008 | EP2000154A2 Composition for preparation of radioactive pharmaceutical for diagnosis of regional cerebral blood flow |
12/10/2008 | EP2000149A1 Chimeric anti-CD20 antibody |
12/10/2008 | EP2000148A1 Compositions and methods for the diagnosis and treatment of prostate cancer |
12/10/2008 | EP1999109A2 Styrylpyridine derivatives and their use for binding and imaging amyloid plaques |